Aller au contenu principal
logo

Convert Pharmaceuticals conducts research and development activities in the field of tumor hypoxia, aiming to bring novel therapeutic agents through to clinical proof-of-concept, with indication and patient selection guided by appropriate biomarkers.

Aires thérapeutiques
Catégorie de membre